Given that PPARα regulates the expression of CD36 in fatty acid metabolism, it may be possible in the future to utilize PPARα to inhibit CD36 expression or block its function, thereby providing a potential therapeutic approach for inhibiting cancer cell metastasis. Here, CD36 is linked to cancer.